Drug
GLPG-2737 clinical trials
Also written GLPG2737.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2016
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses GLPG-2737 is read from its arms, and is right about nine times in ten.
Testing it · 4
- A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)TerminatedPhase 2Galapagos NVNCT04578548Written as GLPG2737
- GLPG2737 on Top of Orkambi in Subjects With Cystic FibrosisCompletedPhase 2Galapagos NVNCT03474042Written as GLPG2737
- Pharmacokinetics of GLPG2737 in Male Subjects With Cystic FibrosisCompletedPhase 1Galapagos NVNCT03450720Written as GLPG2737 single dose
- A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2737 in Healthy SubjectsCompletedPhase 1Lakefront Biotherapeutics NVNCT03410979Written as GLPG2737 single dose